✦ LIBER ✦

Understanding and Controlling Chronic Immune Activation in the HIV-Infected Patients Suppressed on Combination Antiretroviral Therapy

✍ Scribed by Babafemi Taiwo, Luis Barcena, Randall Tressler

Book ID: 120953852
Publisher: Springer
Year: 2012
Tongue: English
Weight: 285 KB
Volume: 10
Category: Article
ISSN: 1548-3568
DOI: 10.1007/s11904-012-0147-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

HIV-infected children with moderate/seve

HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy

✍ S. RESINO; I. GALÁN; A. PÉREZ; J. A. LEÓN; E. SEOANE; D. GURBINDO; M. ÁNGELES MU 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB

DNA Immunization with HIV Early Genes in

DNA Immunization with HIV Early Genes in HIV Type 1-Infected Patients on Highly Active Antiretroviral Therapy

✍ Hejdeman, B.; Boström, A.-C.; Matsuda, R.; Calarota, S.; Lenkei, R.; Fredriksson 📂 Article 📅 2004 🏛 Mary Ann Liebert 🌐 English ⚖ 248 KB

Toxoplasma encephalitis in an HIV-infect

Toxoplasma encephalitis in an HIV-infected patient on highly active antiretroviral therapy despite sustained immune response

✍ Atreya, A. R.; Arora, S.; Gadiraju, V. T.; Martagon-Villamil, J.; Skiest, D. J. 📂 Article 📅 2013 🏛 Royal Society of Medicine Press 🌐 English ⚖ 254 KB

The effect of combination antiretroviral

The effect of combination antiretroviral therapy on CD5 B- cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients

✍ BE Redgrave; SF Stone; MAH French; R Krueger; IR James; P Price 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Effects of potent antiretroviral therapy

Effects of potent antiretroviral therapy on the immune activation marker soluble CD27 in patients infected with HIV-1 subtypes A–D

✍ Ann Atlas; Tran Thi Thanh Ha; Anna Lindström; Anna Nilsson; Annette Alaeus; Fran 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

## Abstract HIV‐1 genetic subtypes might have a different impact on disease progression and response to antiretroviral therapy (ART). Few data are available on the immune activation profile in patients with different HIV‐1 subtypes. We have tested by ELISA the plasma levels of an immune activation

Oral candidiasis and seborrheic dermatit

Oral candidiasis and seborrheic dermatitis in HIV-infected patients on highly active antiretroviral therapy

✍ I Dunic; S Vesic; DJ Jevtovic 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 273 KB